Age & purpose verification
PeptideSeed supplies research compounds for in-vitro laboratory use only. By entering this site you confirm:
Research use only. Not for human or veterinary consumption. Full terms of supply
What a co-lyophilized blend is, how Wolverine, GLOW and KLOW are formulated and assayed, and what changes about reconstituting a multi-component vial.
A co-lyophilized blend is two or more peptides freeze-dried together into a single cake within one vial, rather than each peptide being lyophilized separately and mixed later at the bench. The result looks like any other lyophilized vial, but drawing it reconstitutes a fixed-ratio mixture rather than a single sequence.
This is different from simply reconstituting two separate vials into the same tube. Co-lyophilization happens before the final freeze-drying step, at the manufacturing stage, and the stated ratio is fixed at that point rather than something the end user assembles.
The pairs and combinations offered as blends in this catalogue are, without exception, the sequences most frequently ordered together. A co-lyophilized format removes one reconstitution step and one source of measurement error relative to preparing each component separately and combining them by hand.
It also simplifies inventory and dosing math for a bench protocol that always uses the same two or more sequences at the same ratio - one vial, one reconstitution, one concentration calculation, rather than juggling several source vials.
Wolverine Blend combines BPC-157 and TB-500 at a 1:1 mass ratio - a 10 mg vial contains 5 mg of each, a 20 mg vial contains 10 mg of each. It is the simplest blend in the catalogue and a useful reference case for how the format works before moving to the three- and four-component versions.
Because TB-500 dissolves more slowly than BPC-157, the blend inherits TB-500's reconstitution timeline. A partially dissolved cake will not deliver the stated 1:1 ratio in an early aliquot, since the undissolved fraction is disproportionately the slower component.
GLOW Blend extends the format to three components: 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500 in a 70 mg vial. KLOW Blend adds a fourth: the same GLOW composition plus 10 mg of KPV, for 80 mg total.
Both blends inherit GHK-Cu's handling requirements rather than the milder handling of the peptide-only components, because the copper complex is the most light-sensitive material in either mixture. The pale blue cast of both cakes - lighter than a pure GHK-Cu vial because of dilution by the colourless peptides - is the expected appearance, not a sign of under-strength copper content.
Each constituent is assayed independently by HPLC and LAL before blending, and the finished blend is re-assayed after lyophilization. For KLOW that means five separate certificates - four component assays plus the post-blend assay - all published against the single blend lot number.
This is a meaningfully more thorough documentation trail than a single-component vial carries, precisely because a blend has more places for something to go wrong during formulation and more value in confirming the finished ratio rather than assuming it from the inputs.
The general rule for any multi-component blend is to let the slowest-dissolving constituent set the timeline. Direct diluent against the vial wall as with any lyophilized cake, and resist the urge to draw an aliquot the moment the solution looks clear if a component with a known slower dissolution profile is present.
Do not attempt to separate the components of a blend after reconstitution - they are in solution together and cannot be selectively withdrawn. If a protocol needs the components at a ratio other than what the blend provides, the individual vials remain stocked separately for that purpose.
This guide is general laboratory reference material relating to the handling of research compounds. It is not medical, veterinary or clinical guidance, and it does not describe or imply any use in humans or animals. All PeptideSeed material is supplied for in-vitro laboratory research only — see the terms of supply.